| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM | $69.7M | 315K | ▲New +315K sh | Q4 2025 | |
| 2 | NORGES BANK | $44.2M | 200K | ▲New +200K sh | Q4 2025 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Company | Co-held by | Combined value |
|---|---|---|
| ENDEAVOUR SILVER CORPEXK | 50 funds | $181.3M |
| AMAZON.COM INCAMZN | 49 funds | $17.7B |
| WARNER BROS DISCOVERY INCWBD | 49 funds | $3.3B |
| HOLOGIC INCHO1 | 49 funds | $2.0B |
| NVIDIA CORPNVDA | 48 funds | $34.5B |
| MICROSOFT CORPMSFT | 48 funds | $22.0B |
| BROADCOM INCAVGO | 48 funds | $12.8B |
| ELECTRONIC ARTS INCEA | 48 funds | $3.1B |
| KENVUE INCKVUE | 48 funds | $1.6B |
| AMICUS THERAPEUTICS INCAM6 | 48 funds | $600.8M |
| AVIDITY BIOSCIENCES INCRNAGBP | 48 funds | $268.1M |
| ALPHABET INC-CL AGOOGL | 47 funds | $13.5B |
Ranked by how many of CDTX's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Dec 10, 2025 | Ward Shane | COO & CLO | Sell (S) | 10K | $2.2M |
| Sep 11, 2025 | Davarpanah Nicole Negar | Chief Medical Officer | Sell (S) | 474 | $30K |
| Jun 26, 2025 | Kolchinsky Peter | Director, 10% Owner | Buy (P) | 2.3M | $100.0M |
| Jun 3, 2025 | Mineo Chrysa | Director | Buy (P) | 1K | $25K |
| Jun 2, 2025 | Mineo Chrysa | Director | Buy (P) | 2K | $49K |
| Mar 11, 2025 | Tari Leslie | CHIEF SCIENTIFIC OFFICER | Sell (S) | 2K | $39K |
| Mar 11, 2025 | Ward Shane | COO & CLO | Sell (S) | 2K | $37K |
| Sep 11, 2024 | Tari Leslie | CHIEF SCIENTIFIC OFFICER | Sell (S) | 909 | $11K |
| Sep 11, 2024 | Sandison Taylor | Chief Medical Officer | Sell (S) | 924 | $11K |
| Jun 7, 2024 | Stein Jeffrey | President & CEO, Director | Buy (P) | 8K | $106K |
| Mar 11, 2024 | Shah Preetam | CFO & CBO | Sell (S) | 19K | $13K |
| Mar 11, 2024 | Ward Shane | COO & CLO | Sell (S) | 20K | $14K |
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/CDTX/capital-change-brief"
Use Arkolith's capital_change_brief for CDTX. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for CDTX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.